Press release
RNA-Based Therapies Industry Analysis 2025 | Growth, USA Market Size - Most Leading Companies - Alnylam Pharmaceuticals, NS Pharma, Sarepta Therapeutics, Modern Therapeutics, Biogen
Credits of Image: https://www.europeanpharmaceuticalreview.com/
According to DataM Intelligence has published its latest report on the "RNA-based Therapies Market Size 2025," delivering comprehensive insights into key growth drivers, market segmentation, regional trends, and competitive revenue analysis. The report highlights the market size in both value and volume, CAGR projections, and emerging opportunities that help businesses identify growth potential and craft winning strategies. With a clear, data-driven outlook on current developments and future trends, this research is a must-read for companies seeking to stay ahead in Market.
For example, while each rare disease affects only a small population, there are over 7,000 types globally, impacting around 300 million people. These conditions are often overlooked, especially in low- and middle-income countries.
For example, in May 2025, Eli Lilly partnered with South Korea's Rznomics to develop RNA-editing therapies for sensorineural hearing loss using Rznomics' proprietary trans-splicing ribozyme platform.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/rna-based-therapies-market?kb
Top Key Companies:
Sarepta Therapeutics, Alnylam Pharmaceuticals, NS Pharma, Pfizer, Modern Therapeutics, Novartis, Biogen, and Novo Nordisk among others.
Key Industry Developments:
In January 2025, Denmark's nverna Therapeutics, co-founded by the University of Southern Denmark and Argobio, launched as an advanced RNA therapeutics company, focusing initially on Huntington's disease to improve patient outcomes.
For example, in November 2024, Trace Neuroscience, founded in January, secured $101M in a Series A round to advance its antisense oligonucleotide (ASO) therapy for ALS, a disease popularized by the Ice Bucket Challenge.
In September 2024, Aurora Biosynthetic introduced a new end-to-end solution for GMP production of plasmid DNA, mRNA, and lipid nanoparticles, advancing RNA therapeutics manufacturing across the Asia-Pacific region.
Growth Projection:
The Global RNA-based Therapies Market is set to witness significant growth between 2025 and 2032. While 2024 reflects steady progress, the increasing adoption of innovative strategies by leading players is expected to accelerate growth across the projected horizon. This creates a strong landscape of opportunities for businesses looking to expand, invest, and stay competitive in a rapidly evolving market.
Market Intelligence Research Process:
The RNA-based Therapies Market research report by DataM Intelligence leverages both primary and secondary data sources to deliver deep insights. It explores a wide range of factors shaping the industry from government regulations, market conditions, and competitive dynamics to historical trends, technological advancements, upcoming innovations, and potential challenges. This comprehensive analysis highlights growth prospects while addressing barriers, helping businesses navigate volatility and seize new opportunities
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=rna-based-therapies-market
Key Market Segments:
Type: Antisense Oligonucleotides (ASO) expected to hold 25.51% of RNA Therapies market.
Global Growth Regions:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Introduces the report with an overview of coverage summarizing key market segments by region, product type, and application. It offers a clear snapshot of market size, segment-wise growth potential, and both short- and long-term industry outlook.
Chapter 2: Brings forward the most valuable market insights and reveals the game-changing emerging trends shaping the industry's future.
Chapter 3: Provides a detailed analysis of the competitive landscape among RNA-based Therapies covering revenue shares, strategic initiatives, and the latest mergers & acquisitions.
Chapter 4: Delivers comprehensive profiles of top players, including revenue, profit margins, product lines, and company milestones.
Chapters 5 & 6: Break down revenue performance across regions and countries, offering a precise view of market sizes, opportunities, and development prospects worldwide.
Chapter 7: Examines segmentation by type, revealing the size and potential of each category guiding businesses toward untapped, high-impact areas.
Chapter 8: Focuses on applications, evaluating how different downstream markets are growing and identifying promising sectors for expansion.
Chapter 9: Maps the entire industry supply chain, detailing both upstream and downstream activities for a holistic understanding.
Chapter 10: Concludes with key findings and the most critical takeaways giving stakeholders a clear direction for future strategies.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rna-based-therapies-market?kb
FAQ's
Q1: How fast is the RNA-based Therapies Market growing?
A: The market is set to grow at a CAGR of 10.0% between 2025 and 2032, showing steady global expansion.
Q2: Which Regions lead the RNA-based Therapies Market?
A: North America held a 42.1% share of the global RNA-based therapies market in 2024.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA-Based Therapies Industry Analysis 2025 | Growth, USA Market Size - Most Leading Companies - Alnylam Pharmaceuticals, NS Pharma, Sarepta Therapeutics, Modern Therapeutics, Biogen here
News-ID: 4199827 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Skin Allergy Testing Industry Analysis: Growth Drivers, Regional Outlook & Leade …
skin allergy testing market size reached US$617.31Million in 2024 from US$579.32 Millionin 2023 and is expected to reach US$ 1,136.83 Million by 2033, growing at a CAGR of 7.1%during the forecast period 2025-2033.
According to DataM Intelligence has published its latest report on the "Skin Allergy Testing Market Size 2025," delivering comprehensive insights into key growth drivers, market segmentation, regional trends, and competitive revenue analysis. The report highlights the market size…
Protein Expression & Purification Services Industry Intelligence Report By DataM …
protein expression & purification services market reached US$ 3.96 billion in 2023, with a rise to US$ 4.30 billion in 2024, and is expected to reach US$ 8.95 billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033.
According to DataM Intelligence has published its latest report on the "Protein Expression & Purification Services Market Size 2025," delivering comprehensive insights into key growth drivers, market segmentation,…
United States Non-Alcoholic Beer Market Size & Growth Forecast 2025-2035: Health …
The Global Non-Alcoholic Beer Market reached US$ 20.2 billion in 2022 and is expected to reach US$ 28.7 billion by 2031 and grow with a CAGR of 4.5% during the forecast period 2024-2031.
The Non-alcoholic beer Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including…
US Low-Dose Naltrexone (LDN) & Methylene Blue Telemedicine Industry Growth Insig …
US low-dose naltrexone (LDN) & methylene blue telemedicine market was valued at US$ 281.40 Million in 2023. The market size reached US$ 293.30 Million in 2024 and is expected to reach US$ 436.43 Million by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.
According to DataM Intelligence has published its latest report on the "US Low-Dose Naltrexone (LDN) & Methylene Blue Telemedicine Market Size 2025," delivering comprehensive…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
